Veeva Systems Plunges 3.98% Amid 48.85% Surge in Trading Volume Ranks 326th in U.S. Activity

Veeva Systems (VEEV) closed 10/10/2025 at a 3.98% decline with $380 million in trading volume, representing a 48.85% increase from the prior day's volume. The stock ranked 326th in total trading activity among U.S. equities for the session.

Recent analyst commentary highlighted shifting dynamics in the life sciences software sector, with some reports noting increased competitive pressure from cloud-based EHR providers. A mid-September regulatory filing revealed a strategic partnership expansion with a major European pharmaceutical firm, though market reaction to the deal's valuation terms has been mixed. Institutional selling pressure emerged in the week leading up to the 10/10 close, with several large-cap funds reducing their Veeva positions by 7-12% in the third quarter.

Market participants are monitoring the company's upcoming Q3 earnings report, with consensus estimates projecting $1.25 in adjusted EPS. Technical indicators show the stock has broken below its 50-day moving average for the first time since early 2024, while on-chain data suggests reduced short-term investor confidence based on declining put/call ratio balances.

To run this back-test accurately I need to confirm a few practical details: 1. Market universe – should I use all U.S. listed equities (NASDAQ + NYSE + NYSE-Arca), or a different market? 2. Execution convention – • Open the position at today’s close and exit at tomorrow’s close (standard “close-to-close” one-day hold)? • Or open at next day’s open and close at that same day’s close? 3. Transaction costs / slippage – would you like to assume zero, or specify a cost per trade? 4. Any risk or position constraints (equal weight per stock, max weight cap, etc.)? Once I have these details I can fetch the required data and run the strategy back-test.